Taken together these results indicate that at least some aspects of TDP-43 toxicity are caused by alterations in specific carnitine shuttle components, and manipulating their expression genetically mitigates locomotor dysfunction in our Drosophila model of ALS. Here, TARDBP is linked to amyotrophic lateral sclerosis.